Linked Life Data

2657601

Source:http://linkedlifedata.com/resource/pubmed/id/2657601

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1989-7-11
pubmed:abstractText
The need for a vaccine(s) against cutaneous leishmaniasis and the populations at risk for whom such vaccines should be developed are briefly discussed. The current human vaccine studies are reviewed, as are some experimental mouse studies with emphasis on Leishmania major infection relevant to vaccine development. Based on the information available from the mouse model and those data which are being sought in human studies, the benign nature of the cutaneous disease, the ease with which L. major can be manipulated to yield the required material, and the ongoing practice of leishmanization which allows rapid evaluation of candidate vaccine(s), it is suggested that a vaccine, at least against L. major, is imminent in the not too distant future.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0031-1820
pubmed:author
pubmed:issnType
Print
pubmed:volume
98 Suppl
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S49-60
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Experiences with vaccines against cutaneous leishmaniasis: of men and mice.
pubmed:affiliation
UNDP/World Bank WHO Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland.
pubmed:publicationType
Journal Article, Review